Immediate Impact

2 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
3 intermediate papers

Works of V. Borroni being referenced

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
2016

Author Peers

Author Last Decade Papers Cites
V. Borroni 138 21 22 65 42 10 196
CP Day 159 39 28 60 62 7 224
P. Buffier 135 15 57 105 26 18 254
Milena Stanković 83 44 22 42 22 10 249
Magalie Boucher 73 29 12 21 30 14 189
E.A. Pulixi 97 17 3 27 57 14 220
Letizia Zeni 49 15 23 42 27 13 253
Alexander S. Christensen 43 37 4 102 8 13 255
Christina‐Maria Flessa 185 72 24 68 47 11 287
Karin Diggle 107 38 15 16 64 12 263
Sarah M. Nordstrom 118 60 72 139 7 11 279

All Works

Loading papers...

Rankless by CCL
2026